US2017223964A1PendingUtilityA1

Combination of Novel Nitrification Inhibitors and Herbicides as Well as Combination of (Thio)Phosphoric Acid Triamides and Herbicides

44
Assignee: BASF SEPriority: Apr 17, 2014Filed: Apr 16, 2015Published: Aug 10, 2017
Est. expiryApr 17, 2034(~7.8 yrs left)· nominal 20-yr term from priority
C05G 3/60A01N 57/12C05G 3/90A01N 31/14C05C 1/02A01N 43/54A01N 39/04A01N 57/20A01N 43/10C05G 3/02C05G 3/08Y02P60/21
44
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A composition including (a) at least one (thio)phosphoric acid triamide (T) according to the general formula (Ia) R a1 R a2 N—P(X)(NH 2 ) 2   (Ia) wherein X is oxygen or sulfur; R a1 is a C 1 to C 20 alkyl, C 3 to C 20 cycloalkyl, C 6 to C 20 aryl, or dialkylaminocarbonyl group; R a2 is H; or R a1 and R a2 together with the nitrogen atom linking them define a 5- or 6-membered saturated or unsaturated heterocyclic radical, which optionally comprises 1 or 2 further heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur; and (b) at least one specific herbicide.

Claims

exact text as granted — not AI-modified
1 . A composition comprising:
 a) at least one (thio)phosphoric acid triamide (T) according to the general formula (Ia)
   R a1 R a2 N—P(X)(NH 2 ) 2   (Ia)
 
   wherein   X is oxygen or sulfur;   R a1  is a C 1  to C 20  alkyl, C 3  to C 20  cycloalkyl, C 6  to C 20  aryl, or dialkylaminocarbonyl group;   R a2  is H, or   R a1  and R a2  together with the nitrogen atom linking them define a 5- or 6-membered saturated or unsaturated heterocyclic radical, which optionally comprises 1 or 2 further heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur;   and   b) at least one herbicide selected from the group consisting of:   (i) amino acid derivatives selected from the group consisting of glyphosate (B.2.1), glufosinate (B.2.2), sulfosate (B.2.3), and bilanafos;   (ii) acetamides selected from the group consisting of acetochlor (B.1.1), alachlor, butachlor, dimethachlor, dimethenamid (B.1.2), flufenacet (B.1.3), mefenacet (B.1.4), metolachlor (B.1.5), metazachlor (B.1.6), napropamide, naproanilide, pethoxamid, pretilachlor, propachlor, and thenylchlor;   (iii) aryloxyphenoxypropionates selected from the group consisting of clodinafop (B.3.1), cyhalofop-butyl, fenoxaprop (B.3.2), fluazifop (B.3.3), haloxyfop (B.3.4), metamifop, propaquizafop (B.3.5), quizalofop, and quizalofop-P-tefuryl;   (iv) bipyridyls selected from the group consisting of diquat, and paraquat (B.4.1);   (v) (thio)carbamates selected from the group consisting of asulam, butylate, carbetamide, desmedipham, dimepiperate, eptam (EPTC), esprocarb, molinate, orbencarb, phenmedipham (B.5.1), prosulfocarb, pyributicarb, thiobencarb, and triallate;   (vi) cyclohexanediones selected from the group consisting of butroxydim, clethodim (B.6.1), cycloxydim (B.6.2), profoxydim (B.6.3), sethoxydim (B.6.4), tepraloxydim (B.6.5), and tralkoxydim;   (vii) dinitroanilines selected from the group consisting of benfluralin, ethalfluralin, oryzalin, pendimethalin (B.7.1), prodiamine (B.7.2), and trifluralin (B.7.3);   (viii) diphenyl ethers selected from the group consisting of acifluorfen (B.8.1), aclonifen, bifenox, diclofop, ethoxyfen, fomesafen, lactofen, and oxyfluorfen;   (ix) hydroxybenzonitriles selected from the group consisting of bomoxynil (B.9.1), dichlobenil, and ioxynil;   (x) imidazolinones selected from the group consisting of imazamethabenz, imazamox (B.10.1), imazapic (B.10.2), imazapyr (B.10.3), imazaquin (B.10.4), and imazethapyr (B.10.5);   (xi) phenoxy acetic acids selected from the group consisting of clomeprop, 2,4-dichlorophenoxyacetic acid (2,4-D) (B.11.1), 2,4-DB, dichlorprop, MCPA, MCPA-thioethyl, MCPB, and Mecoprop;   (xii) pyrazines selected from the group consisting of chloridazon (B.11.2), flufenpyr-ethyl, fluthiacet, norflurazon, and pyridate;   (xiii) pyridines selected from the group consisting of aminopyralid, clopyralid (B.12.1), diflufenican, dithiopyr, fluridone, fluroxypyr (B.12.2), picloram (B.12.3), picolinafen (B.12.4), and thiazopyr;   (xiv) sulfonyl ureas selected from the group consisting of amidosulfuron, azimsulfuron, bensulfuron (B.13.1), chlorimuron-ethyl (B.13.2), chlorsulfuron, cinosulfuron, cyclosulfamuron (B.13.3), ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, foramsulfuron, halosulfuron, imazosulfuron, iodosulfuron (B.13.4), mesosulfuron (B.13.5), metazosulfuron, metsulfuron-methyl (B.13.6), nicosulfuron (B.13.7), oxasulfuron, primisulfuron, prosulfuron, pyrazosulfuron, rimsulfuron (B.13.8), sulfometuron, sulfosulfuron, thifensulfuron, triasulfuron, tribenuron (B.13.10), trifloxysulfuron, triflusulfuron (B.13.9), tritosulfuron, and 1-((2-chloro-6-propyl-imidazo[1,2-b]pyridazin-3-yl)sulfonyl)-3-(4,6-dimethoxy-pyrimidin-2-yl)urea;   (xv) triazines selected from the group consisting of ametryn, atrazine (B.14.1), cyanazine, dimethametryn, ethiozin, hexazinone (B.14.2), metamitron, metribuzin, prometryn, simazine, terbuthylazine, terbutryn, and triaziflam;   (xvi) ureas selected from the group consisting of chlorotoluron, daimuron, diuron (B.15.1), fluometuron, isoproturon, linuron, methabenzthiazuron, and tebuthiuron;   (xvii) other acetolactate synthase inhibitors selected from the group consisting of bispyribac-sodium, cloransulam-methyl, diclosulam, florasulam (B.16.1), flucarbazone, flumetsulam, metosulam, ortho-sulfamuron, penoxsulam, propoxycarbazone, pyribambenz-propyl, pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyroxasulfone (B.16.2), and pyroxsulam; and   (xviii) amicarbazone, aminotriazole, anilofos, beflubutamid, benazolin, bencarbazone, benfluresate, benzofenap, bentazone (B.17.1), benzobicyclon, bicyclopyrone, bromacil, bromobutide, butafenacil, butamifos, cafenstrole, carfentrazone, cinidon-ethyl (B.17.2), chlorthal, cinmethylin (B.17.3), clomazone (B.17.4), cumyluron, cyprosulfamide, dicamba (B.17.5), difenzoquat, diflufenzopyr (B.17.6),  Drechslera monoceras , endothal, ethofumesate, etobenzanid, fenoxasulfone, fentrazamide, flumiclorac-pentyl, flumioxazin, flupoxam, flurochloridone, flurtamone, indanofan, isoxaben, isoxaflutole, lenacil, propanil, propyzamide, quinclorac (B.17.7), quinmerac (B.17.8), mesotrione (B.17.9), methyl arsonic acid, naptalam, oxadiargyl, oxadiazon, oxaziclomefone, pentoxazone, pinoxaden, pyraclonil, pyraflufen-ethyl, pyrasulfotole, pyrazoxyfen, pyrazolynate, quinoclamine, saflufenacil (B.17.10), sulcotrione (B.17.11), sulfentrazone, terbacil, tefuryltrione, tembotrione, thiencarbazone, topramezone (B.17.12), (3-[2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydro-2H-pyrimidin-1-yl)-phenoxy]-pyridin-2-yloxy)-acetic acid ethyl ester, 6-amino-5-chloro-2-cyclopropyl-pyrimidine-4-carboxylic acid methyl ester, 6-chloro-3-(2-cyclopropyl-6-methyl-phenoxy)-pyridazin-4-ol, 4-amino-3-chloro-6-(4-chloro-phenyl)-5-fluoro-pyridine-2-carboxylic acid, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxy-phenyl)-pyridine-2-carboxylic acid methyl ester, and 4-amino-3-chloro-6-(4-chloro-3-dimethylamino-2-fluoro-phenyl)-pyridine-2-carboxylic acid methyl ester.   
     
     
         2 . The composition according to  claim 1 , wherein in the general formula (Ia) of (T) X is sulfur. 
     
     
         3 . The composition according to  claim 1 , wherein in the general formula (Ia) of (T) R a1  is C 1 -C 20  alkyl and R a2  is H. 
     
     
         4 . The composition according to  claim 1 , wherein the (thio)phosphoric acid triamide (T) is one of N-n-butylthiophosphoric acid triamide (NBPT) and N-n-propylthiophosphoric acid triamide (NPPT). 
     
     
         5 . The composition according to  claim 1 , wherein the herbicide is a herbicide selected from the group consisting of dicamba (B.17.5), glyphosate (B.2.1), propaquizafop (B.3.5), cycloxydim (B.6.2), bomoxynil (B.9.1), imazamox (B.10.1), nicosulfuron (B.13.7), tribenuron (B.13.10), saflufenacil (B.17.10), topramezone (B.17.2), dimethenamid (B.1.2), and 2,4-dichlorophenoxyacetic acid (2,4-D) (B.11.1). 
     
     
         6 . A method for at least one of increasing the health of a plant and increasing the herbicidal activity of a herbicide, the method comprising:
 treating at least one of (a) a plant growing on at least one of soil or soil substituents, and (b) and at least one of the locus, soil, and soil substituents where the plant is at least one of growing or intended to grow, with   a) at least one (thio)phosphoric acid triamide (T) according to the general formula (Ia)
   R a1 R a2 N—P(X)(NH 2 ) 2   (Ia)
 
   wherein   X is oxygen or sulfur;   R a1  is a C 1  to C 20  alkyl, C 3  to C 20  cycloalkyl, C 6  to C 20  aryl, or dialkylaminocarbonyl group;   R a2  is H, or   R a1  and R a2  together with the nitrogen atom linking them define a 5- or 6-membered saturated or unsaturated heterocyclic radical, which optionally comprises 1 or 2 further heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur   and   b) at least one herbicide selected from the group consisting of   (i) amino acid derivatives selected from the group consisting of glyphosate (B.2.1), glufosinate (B.2.2), sulfosate (B.2.3), and bilanafos;   (ii) acetamides selected from the group consisting of acetochlor (B.1.1), alachlor, butachlor, dimethachlor, dimethenamid (B.1.2), flufenacet (B.1.3), mefenacet (B.1.4), metolachlor (B.1.5), metazachlor (B.1.6), napropamide, naproanilide, pethoxamid, pretilachlor, propachlor, and thenylchlor;   (iii) aryloxyphenoxypropionates selected from the group consisting of clodinafop (B.3.1), cyhalofop-butyl, fenoxaprop (B.3.2), fluazifop (B.3.3), haloxyfop (B.3.4), metamifop, propaquizafop (B.3.5), quizalofop, and quizalofop-P-tefuryl;   (iv) bipyridyls selected from the group consisting of diquat, and paraquat (B.4.1);   (v) (thio)carbamates selected from the group consisting of asulam, butylate, carbetamide, desmedipham, dimepiperate, eptam (EPTC), esprocarb, molinate, orbencarb, phenmedipham (B.5.1), prosulfocarb, pyributicarb, thiobencarb, and triallate;   (vi) cyclohexanediones selected from the group consisting of butroxydim, clethodim (B.6.1), cycloxydim (B.6.2), profoxydim (B.6.3), sethoxydim (B.6.4), tepraloxydim (B.6.5), and tralkoxydim;   (vii) dinitroanilines selected from the group consisting of benfluralin, ethalfluralin, oryzalin, pendimethalin (B.7.1), prodiamine (B.7.2), and trifluralin (B.7.3);   (viii) diphenyl ethers selected from the group consisting of acifluorfen (B.8.1), aclonifen, bifenox, diclofop, ethoxyfen, fomesafen, lactofen, and oxyfluorfen;   (ix) hydroxybenzonitriles selected from the group consisting of bomoxynil (B.9.1), dichlobenil, and ioxynil;   (x) imidazolinones selected from the group consisting of imazamethabenz, imazamox (B.10.1), imazapic (B.10.2), imazapyr (B.10.3), imazaquin (B.10.4), and imazethapyr (B.10.5);   (xi) phenoxy acetic acids selected from the group consisting of clomeprop, 2,4-dichlorophenoxyacetic acid (2,4-D) (B.11.1), 2,4-DB, dichlorprop, MCPA, MCPA-thioethyl, MCPB, and Mecoprop;   (xii) pyrazines selected from the group consisting of chloridazon (B.11.2), flufenpyr-ethyl, fluthiacet, norflurazon, and pyridate;   (xiii) pyridines selected from the group consisting of aminopyralid, clopyralid (B.12.1), diflufenican, dithiopyr, fluridone, fluroxypyr (B.12.2), picloram (B.12.3), picolinafen (B.12.4), and thiazopyr;   (xiv) sulfonyl ureas selected from the group consisting of amidosulfuron, azimsulfuron, bensulfuron (B.13.1), chlorimuron-ethyl (B.13.2), chlorsulfuron, cinosulfuron, cyclosulfamuron (B.13.3), ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, foramsulfuron, halosulfuron, imazosulfuron, iodosulfuron (B.13.4), mesosulfuron (B.13.5), metazosulfuron, metsulfuron-methyl (B.13.6), nicosulfuron (B.13.7), oxasulfuron, primisulfuron, prosulfuron, pyrazosulfuron, rimsulfuron (B.13.8), sulfometuron, sulfosulfuron, thifensulfuron, triasulfuron, tribenuron (B.13.10), trifloxysulfuron, triflusulfuron (B.13.9), tritosulfuron, and 1-((2-chloro-6-propyl-imidazo[1,2-b]pyridazin-3-yl)sulfonyl)-3-(4,6-dimethoxy-pyrimidin-2-yl)urea;   (xv) triazines selected from the group consisting of ametryn, atrazine (B.14.1), cyanazine, dimethametryn, ethiozin, hexazinone (B.14.2), metamitron, metribuzin, prometryn, simazine, terbuthylazine, terbutryn, and triaziflam;   (xvi) ureas selected from the group consisting of chlorotoluron, daimuron, diuron (B.15.1), fluometuron, isoproturon, linuron, methabenzthiazuron, and tebuthiuron;   (xvii) other acetolactate synthase inhibitors selected from the group consisting of bispyribac-sodium, cloransulam-methyl, diclosulam, florasulam (B.16.1), flucarbazone, flumetsulam, metosulam, ortho-sulfamuron, penoxsulam, propoxycarbazone, pyribambenz-propyl, pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyroxasulfone (B.16.2), and pyroxsulam; and   (xviii) amicarbazone, aminotriazole, anilofos, beflubutamid, benazolin, bencarbazone, benfluresate, benzofenap, bentazone (B.17.1), benzobicyclon, bicyclopyrone, bromacil, bromobutide, butafenacil, butamifos, cafenstrole, carfentrazone, cinidon-ethyl (B.17.2), chlorthal, cinmethylin (B.17.3), clomazone (B.17.4), cumyluron, cyprosulfamide, dicamba (B.17.5), difenzoquat, diflufenzopyr (B.17.6),  Drechslera monoceras , endothal, ethofumesate, etobenzanid, fenoxasulfone, fentrazamide, flumiclorac-pentyl, flumioxazin, flupoxam, flurochloridone, flurtamone, indanofan, isoxaben, isoxaflutole, lenacil, propanil, propyzamide, quinclorac (B.17.7), quinmerac (B.17.8), mesotrione (B.17.9), methyl arsonic acid, naptalam, oxadiargyl, oxadiazon, oxaziclomefone, pentoxazone, pinoxaden, pyraclonil, pyraflufen-ethyl, pyrasulfotole, pyrazoxyfen, pyrazolynate, quinoclamine, saflufenacil (B.17.10), sulcotrione (B.17.11), sulfentrazone, terbacil, tefuryltrione, tembotrione, thiencarbazone, topramezone (B.17.12), (3-[2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydro-2H-pyrimidin-1-yl)-phenoxy]-pyridin-2-yloxy)-acetic acid ethyl ester, 6-amino-5-chloro-2-cyclopropyl-pyrimidine-4-carboxylic acid methyl ester, 6-chloro-3-(2-cyclopropyl-6-methyl-phenoxy)-pyridazin-4-ol, 4-amino-3-chloro-6-(4-chloro-phenyl)-5-fluoro-pyridine-2-carboxylic acid, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxy-phenyl)-pyridine-2-carboxylic acid methyl ester, and 4-amino-3-chloro-6-(4-chloro-3-dimethylamino-2-fluoro-phenyl)-pyridine-2-carboxylic acid methyl ester.   
     
     
         7 . The method according to  claim 6 , wherein the plant is additionally provided with a urea-containing fertilizer selected from the group consisting of urea, formaldehyde urea, UAN, urea sulfur, stabilized urea, urea based NPK-fertilizers, and urea ammonium sulfate. 
     
     
         8 . The method according to  claim 6 , wherein the herbicide is selected from the group consisting of dicamba (B.17.5), glyphosate (B.2.1), propaquizafop (B.3.5), cycloxydim (B.6.2), bomoxynil (B.9.1), imazamox (B.10.1), nicosulfuron (B.13.7), tribenuron (B.13.10), saflufenacil (B.17.10), topramezone (B.17.2), dimethenamid (B.1.2), and 2,4-dichlorophenoxyacetic acid (2,4-D) (B.11.1). 
     
     
         9 . The method according to  claim 6 , wherein the application of the (thio)phosphoric acid triamide (T) and the herbicide is carried out simultaneously or with a time lag. 
     
     
         10 . A method for at least one of increasing the health of a plant and increasing the herbicidal activity of the herbicide, the method comprising using the composition of  claim 1 . 
     
     
         11 - 25 . (canceled) 
     
     
         26 . The method according to  claim 9 , wherein the application of the (thio)phosphoric acid triamide (T), the herbicide, and the urea-containing fertilizer is carried out simultaneously or with a time lag. 
     
     
         27 . The method according to  claim 26 , wherein the time lag is an interval selected from the group consisting of 1 day, 2 days, 3 days, 1 week, 2 weeks, and 3 weeks. 
     
     
         28 . The method according to  claim 9 , wherein the time lag is an interval selected from the group consisting of 1 day, 2 days, 3 days, 1 week, 2 weeks, and 3 weeks.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.